Australia's largest stock trading and investment forum Australia's #1 stock forum

RAP

Click for more information

0.00%

20.5¢ raptor resources limited

Ann: ResApp Provides SMARTCOUGH-C-2 Study Update, page-36

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #

First 36 Last

Share
Profile

Follow
demoniaco

6,340 Posts.

250

31/05/18

14:45

Post #: 33407353
Share

Originally posted by TerribleTadpole ↑

In the teleconference they reported that over 70% of the sampled recordings (i.e. the ones they'd listened to) were audibly affected by background noise including televisions, conversations, medical equipment, other patients coughing, and even in some cases "coaching" coughs from parents or staff.

My understanding is that they investigated to the point where they were confident that they'd identified all the distinct causes of sound quality and didn't waste time beyond that.

Not all issues last year were related to data quality. There were also issues with the protocol. Asthma patients were treated already before they were tested by ResappDx. Given that Ventolin has almost immediate effect there was effectively nothing for ResappDx to detect. And finally as the comparison tests were adjudicated by different teams using different criteria there was no stable baseline for measuring results in some of the conditions.

Expand

Glad someone attended the teleconference with a memory!

70% -> 1% is a whopper of a difference.

I'll see you all back at 30c in a couple of months.

RAP Price at posting: 14.5¢ Sentiment: Buy Disclosure: Held
10 Upvote

0 Great analysis

Reply

Top Stories

EEG

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

HotCopper Highlights: Your most watched stocks for Week 46, 2024

3DA

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

BNL

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

IRX

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

CUF

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

CLE

Cyclone signs MOU with Vale for development of Iron Bear play

GDM

Banshee's historic trenches prove rich in antimony and gold for GDM

First 36 Last

Add RAP (ASX) to my watchlist

SPONSORED BY